Sharon Hesterlee, PhD, the chief research officer of MDA, discussed highlights of 2023’s meeting and exciting new things to look forward to at the upcoming 2024 meeting.
Muscular Dystrophy Association
Latest Content
CGTLive spoke with Donald Wood, PhD, president and CEO of the MDA while looking ahead to its March conference.
The chief research officer of the Muscular Dystrophy Association discussed the need for disease-modifying therapies in other muscular dystrophies and programs the association has announced to this end.
The chief research officer of the Muscular Dystrophy Association discussed research needs that remain in the field in light of recent progress and approvals.
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 17, 2025
2
Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA
3
The Implications of the Final Data From Hemgenix’s HOPE-B Trial
4
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
5